AAAAAA

   
Results: 1-11 |
Results: 11
FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53
Authors: BYRD JC SHINN C WASELENKO JK FUCHS EJ LEHMAN TA NGUYEN PL FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53, Blood, 92(10), 1998, pp. 3804-3816
FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS MARKED IN-VITRO ACTIVITY AGAINST BOTH THE K-562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS
Authors: BYRD JC WASELENKO JK SHINN CA MILLER C GORE S SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS MARKED IN-VITRO ACTIVITY AGAINST BOTH THE K-562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3810-3810
UCN-01 HAS SIGNIFICANT IN-VITRO ACTIVITY IN BOTH THE RESISTANT K562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS
Authors: SHINN CA BYRD JC WASELENKO JK SAUSVILLE E MILLER C GORE S GREVER MR
Citation: Ca. Shinn et al., UCN-01 HAS SIGNIFICANT IN-VITRO ACTIVITY IN BOTH THE RESISTANT K562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3848-3848
FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST THE K-562 CELL-LINEAND HUMAN ACUTE-LEUKEMIA CELLS
Authors: WASELENKO JK BYRD JC SHINN CA MILLER C GORE S SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST THE K-562 CELL-LINEAND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3858-3858
UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS
Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 4125-4125
CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO
Authors: WASELENKO JK BYRD JC SHINN CA FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO, Blood, 90(10), 1997, pp. 4147-4147
GEMCITABINE DEMONSTRATES SIGNIFICANT IN-VITRO ACTIVITY IN HEAVILY PRETREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: WASELENKO JK GREVER MR SHINN CA FLINN IW DIEHL LF BYRD JC
Citation: Jk. Waselenko et al., GEMCITABINE DEMONSTRATES SIGNIFICANT IN-VITRO ACTIVITY IN HEAVILY PRETREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 4148-4148
FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS
Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FUCHS E FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 2366-2366
FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: BYRD JC WASELENKO JK SHINN CA BEDI A FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2367-2367
INTERLEUKIN-4 INDUCES RESISTANCE TO F-ARA-A AND UCN-01, BUT NOT FLAVOPIRIDOL IN A BCL-2 INDEPENDENT MANNER
Authors: BYRD JC WASELENKO JK SHINN CA FLINN IW DIEHL LF GREVER M
Citation: Jc. Byrd et al., INTERLEUKIN-4 INDUCES RESISTANCE TO F-ARA-A AND UCN-01, BUT NOT FLAVOPIRIDOL IN A BCL-2 INDEPENDENT MANNER, Blood, 90(10), 1997, pp. 2368-2368
FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION
Authors: WASELENKO JK PRZYGODZKI R GREVER MR SHINN CA SAUSVILLE E BYRD JC
Citation: Jk. Waselenko et al., FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION, Blood, 90(10), 1997, pp. 2369-2369
Risultati: 1-11 |